Yüklüyor......
New developments in the treatment of multiple myeloma – clinical utility of daratumumab
Multiple myeloma is a clonal disorder of plasma cells that is currently considered incurable. CD38 is a 46 kDa type II transmembrane glycoprotein that is highly expressed on myeloma cells. Daratumumab is a first in-class human IgG1 monoclonal antibody that targets CD38, and has antimyeloma effects t...
Kaydedildi:
| Yayımlandı: | Biologics |
|---|---|
| Asıl Yazarlar: | , , |
| Materyal Türü: | Artigo |
| Dil: | Inglês |
| Baskı/Yayın Bilgisi: |
Dove Medical Press
2017
|
| Konular: | |
| Online Erişim: | https://ncbi.nlm.nih.gov/pmc/articles/PMC5395289/ https://ncbi.nlm.nih.gov/pubmed/28442888 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.2147/BTT.S97633 |
| Etiketler: |
Etiketle
Etiket eklenmemiş, İlk siz ekleyin!
|